Study of RP1 Monotherapy and RP1 in Combination With Nivolumab

Conditions:   Cancer;   Melanoma (Skin);   Melanoma, Uveal;   Melanoma, Ocular;   Bladder Cancer;   Mismatch Repair Deficiency;   Microsatellite Instability;   Non-melanoma Skin Cancer Interventions:   Biological: RP1;   Biological: nivolumab Sponsor:   Replimune Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials